Zhenqing Feng Selected Research

Zhenqing Feng Research Topics

Disease

36	Neoplasms (Cancer) 09/2022 - 02/2008
12	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2016
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
7	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 10/2007
5	Lymphatic Metastasis 05/2019 - 01/2016
4	Infections 10/2019 - 04/2002
3	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
2	Communicable Diseases (Infectious Diseases) 12/2022 - 05/2011
2	Anthrax 12/2018 - 07/2015
2	Carcinogenesis 12/2016 - 05/2014
2	Nasopharyngeal Carcinoma 11/2014 - 03/2012
2	Rabies (Hydrophobia) 05/2011 - 04/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022
1	Alcoholism (Alcohol Abuse) 09/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020
1	Testicular Neoplasms (Testicular Cancer) 10/2019
1	Adenocarcinoma of Lung 10/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Cholangiocarcinoma 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2016
1	Multiple Myeloma 01/2016
1	Inflammation (Inflammations) 10/2015
1	Sepsis (Septicemia) 10/2015
1	Necrosis 05/2015
1	Prostatic Intraepithelial Neoplasia 09/2014
1	Prostatic Neoplasms (Prostate Cancer) 09/2014
1	Aneuploidy (Aneuploid) 08/2014
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
5	Chimeric Antigen ReceptorsIBA 12/2021 - 11/2014
4	AntigensIBA 01/2021 - 07/2015
4	Messenger RNA (mRNA)IBA 11/2019 - 01/2016
4	Small Interfering RNA (siRNA)IBA 10/2019 - 02/2008
3	AntibodiesIBA 12/2022 - 05/2011
3	AmphiregulinIBA 10/2019 - 11/2016
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2015 - 01/2010
2	CateninsIBA 01/2022 - 01/2019
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 11/2019
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	Interleukin-2 (IL2)IBA 01/2019 - 11/2014
2	Immunoglobulin G (IgG)IBA 01/2019 - 05/2014
2	Monoclonal AntibodiesIBA 12/2018 - 01/2013
2	Surface Antigens (Surface Antigen)IBA 10/2018 - 03/2014
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2016
2	Neutralizing AntibodiesIBA 07/2015 - 05/2010
2	Caspase 3 (Caspase-3)IBA 05/2015 - 01/2013
2	Immunoglobulin FragmentsIBA 01/2013 - 05/2011
2	Immunotoxins (Immunotoxin)IBA 01/2013 - 03/2011
2	Vascular Endothelial Growth FactorsIBA 09/2011 - 01/2010
2	VaccinesIBA 05/2011 - 04/2002
2	Immunoglobulins (Immunoglobulin)IBA 05/2011 - 04/2011
1	CopperIBA 09/2022
1	Disulfiram (Antabuse)FDA Link 09/2022
1	Transcription Factors (Transcription Factor)IBA 09/2022
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 09/2022
1	Aldehyde DehydrogenaseIBA 09/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Proto-Oncogene Proteins c-metIBA 12/2021
1	Long Noncoding RNAIBA 03/2021
1	Bispecific AntibodiesIBA 01/2021
1	CytokinesIBA 01/2021
1	CD19-specific chimeric antigen receptorIBA 11/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2019
1	EpiregulinIBA 05/2019
1	Epidermal Growth Factor (EGF)IBA 05/2019
1	LigandsIBA 05/2019
1	Peptide Elongation Factors (Elongation Factor)IBA 04/2019
1	ARV-825IBA 01/2019
1	PlatinumIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Sincalide FDA Link 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2018
1	Aurora Kinase AIBA 12/2016
1	matrigelIBA 12/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	N-nitroso-N-methyltyramine (NNMT)IBA 01/2016
1	EnzymesIBA 01/2016
1	Nicotinamide N-MethyltransferaseIBA 01/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	LipopolysaccharidesIBA 10/2015
1	Antiviral Agents (Antivirals)IBA 09/2014
1	3,3'-diindolylmethane (diindolylmethane)IBA 09/2014
1	Gonadal Steroid Hormones (Sex Hormones)IBA 09/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2014
1	VimentinIBA 08/2014
1	Cadherins (E-Cadherin)IBA 08/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	ExotoxinsIBA 01/2013
1	Cytotoxins (Cytolysins)IBA 01/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013
1	EpitopesIBA 01/2013
1	Alkaline PhosphataseIBA 01/2013
1	Single-Chain AntibodiesIBA 01/2013
1	Immunoglobulin Fab FragmentsIBA 01/2013

Therapy/Procedure

10	Therapeutics 01/2021 - 09/2011
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
2	Immunotherapy 01/2022 - 10/2019